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Clinical diagnosis of potentially reversible cartilage degeneration 
using optical coherence tomography
C.R. Chu
Department Of Orthopaedic Surgery, University of Pittsburgh, 
pittsburgh, United States of America
Purpose: This bench to operating room study was conducted to 
determine whether Optical Coherence Tomography (OCT) can be 
used clinically to diagnose potentially reversible early cartilage 
degeneration. 
Methods and Materials: Polarized OCT was used to image articular 
cartilage with surfaces appearing intact to arthroscopic surface 
imaging in human cadavers, in human osteochondral tissues, and 
clinically during knee arthroscopy. The OCT images were graded 
based on the presence or absence of OCT form birefringence. For 
clinical study, polarized OCT was used arthroscopically in 19 human 
subjects (10 males and 9 females) ranging in age from 24 to 80 years. 
Twelve individuals were treated for degenerative medial meniscus 
tears and seven individuals for other intra-articular pathologies. 
Results: )VNBO DBEBWFS TUVEZ DPO¾SNFE SFQSPEVDJCJMJUZ PG 0$5
imaging and grading based on changes to cartilage OCT form 
birefringence. Using osteochondral tissues, metabolic studies 
show that cartilage without OCT form birefringence had reduced 
ability to increase proteoglycan synthetic activity in response to 
Insulin Growth Factor-1 (IGF-1). The bench data further show that 
IGF-1 insensitivity in cartilage without OCT form birefringence was 
potentially reversible. Clinical results show more prevalent loss of 
OCT form birefringence in cartilage of human subjects older than 
age 50 and in those with degenerative medial meniscus tears, two 
groups with higher rates of osteoarthritis. 
Conclusions: The clinical data combined with the laboratory data 
TIPXJOH UIBU MPTT PG DBSUJMBHF 0$5 GPSN CJSFGSJOHFODF JEFOUJ¾FT
potentially reversible early cartilage metabolic incompetence 
suggests that OCT may permit clinical diagnosis of early human 
cartilage degeneration at a potentially treatable stage. 
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Clinical performance and radiographic appearance do not correlate 
in patients with unicompartimental osteoarthritis in the knee joint 
treated with high tibial open wedge osteotomy- a prospective 
clinical and radiographic study
M. Gruber1, S. Nehrer2, J. Sailer3, M. Scheickl1, R. Kotz1;
1Orthopedic Surgery, Medical University Vienna, Vienna, Austria, 
2Center For Rgenerative Medicine, Danube University Krems, Krems, 
Austria, 3Radiology, Medical University Vienna, Vienna, Austria
Purpose: The high tibial open wedge osteotomy (HTOWO) in varus 
knees is an important treatment modality in younger patients with 
unicompartimental osteoarthritis and varus malalignment. This 
prospective clinical and radiographic study evaluates the effect of 
HTOWO on osteoarthritic changes and clinical performance. 
Methods and Materials: A consecutive group of 53 patients (35/18 
NBMF GFNBMF  ZFBST 4%
 XJUI WBSVT NBMBMJHONFOU
and unicompartimental osteoarthritic lesions were treated with 
arthroscopy and HTOWO. Cartilage damage was determined 
intraoperatively according to the Outerbridge-Score, radiographic 
osteoarthritic changes by the Kellgren and Lawrence Score (KLS) 
and clinical performance by the Lysholm Score. Axial alignment was 
measured pre– and postoperatively on a digital long-leg radiograph 
using a PACS-workstation software. The mean follow-up was 21 
months (range 12 to 30 mos). 
Results: 5IF-ZTIPMN4DPSFJODSFBTFETJHOJ¾DBOUMZGSPN	4%
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 5IF QPTUPQFSBUJWF BMJHONFOU
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 SBOHF WBSVT UP WBMHVT
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B NFBO DPSSFDUJPO PG 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 5IF
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
BOEWFSJ¾FEUIF
unicompartimental osteoarthritis, but did not correlate with the 
preoperative Kellgren Score. The KLS pre- and postoperatively was 
NFBO	4%
NFBO	4%
BOEEJEOPUOPUDIBOHF
TJHOJ¾DBOUMZEVSJOHUIFGPMMPXVQQFSJPEUIJTXBTOPUSF¿FDUFEXJUI
the increasing Lysholm Scores. 
Conclusions: HTOWO increased the clinical performance of patients 
with unicompartimental osteoarthritis and hindered further 
radiographic progression of OA. However, the radiographic KLS did 
OPUSF¿FDUUIFHSBEFPGDBSUJMBHFEBNBHFBOEDMJOJDBMQFSGPSNBODF
P18
A powder made from subspecies of Rose-hip may act structure-
modifying in osteoarthritis.
K. Winther
Clinical, Frb, Frederiksberg, Denmark
Purpose:  In clinical trials on osteoarthritis, LitoZinTMJ¿FYTM a 
standardised Rosa canina powder produced by HybenVital, has 
TIPXOBOUJJO¿BNNBUPSZBOEDFMMQSFTFSWJOHDBQBDJUZ5IJTTVCTUVEZ
aimed to support or deny the hypothesis that the powder may act 
structure-modifying in joints with osteoarthritis. 
Methods and Materials: The double-blind, cross-over substudy, 
based on diaries, randomly included patients for treatment with 
either placebo or rosehip powder (5 g daily) for 3 month after which 
the placebo group was changed to active treatment and vice versa. 
Each day pain and stiffness were estimated in the morning and at 
noon on a 10 step categorical scale (10 worst possible). General 
wellbeing, quality of sleep and mood were evaluated once daily 
using similar scales. 
Results: Diaries were available from 47 patients. Pain in the morning 
and pain at noon evaluated after 3 months of active treatment 
TIPXFEBNFBOEFDMJOFPGBOE	Q<0.020 and 
p<0.015) respectively, as compared to placebo. The corresponding 
WBMVFT GPS TUJGGOFTT XBT B EFDMJOF PG  BOE 
(p<0.029 and p<0.035) respectively. General wellbeing, sleeping 
RVBMJUZBOENPPETJHOJ¾DBOUMZJNQSPWFEBTBSFTVMUPGBDUJWFUIFSBQZ
(p<0.016, p<0.009 and p<0.020), respectively. A strong carry-over 
was detected. 
Conclusions:  The data support the hypothesis that the present 
powder may act structure-modifying and encouraged us to plan 
research related to cartilage. 
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Meta-analysis of hyaluronic acid safety
J. Uribe1, I. Sledge2, A. Botto-van Bemden3, K. Fahrbach2, A. Muri2;
1Ortho, UHZSMI, Coral Gables, United States of America, 2Medical,
UBC, Boston, United States of America, 3Orthopaedics, UHZ Sports 
Medicine Institute, Coral Gables, United States of America
Purpose:  To review the best available evidence on the safety of 
hyaluronic acid (HA) injections for the treatment of osteoarthritis of 
the knee and to establish the rate of occurrence of both mild and 
severe adverse events. 
Methods and Materials: A systematic review of the literature and 
NFUBBOBMZTJT 0VUDPNFT NFBTVSFE XFSF SBUFT PG TQFDJ¾D MPDBM
adverse events. 
Results: There are 74 interventional studies with 11,377 patients in 
the analysis. Fifty of the studies were randomized controlled trials 
(RCTs). The mean age of the patients at baseline was 63.6 years. 
The largest number of studies was of Synvisc (26) and Hyalgan (24). 
The most commonly reported local adverse event was a mild local 
reaction not requiring treatment. This mild reaction was reported 
in 46 treatment arms (3,975 patients) and occurred in 11.7% of 
QBUJFOUT 	 DPO¾EFODF JOUFSWBM  UP 
 5IF SBUF PG TFWFSF
local reactions was 0.4%. Adverse events in placebo groups were 
rare with the exception of mild local reactions. The major difference 
seen in adverse events between 3 and 5 injection products is the 
rate of severe local reactions. [0.7% (0.2 - 1.2) for 3-injection and 
0.04 (0.0-0.2) for 5-injection products]. 
Conclusions:  5IF QSJNBSZ ¾OEJOHT PG UIJT SFWJFX JOEJDBUF UIBU
adverse event rates are low across all commercially available HA 
products. Mild local reaction rates are comparable across products; 
however, the rate of severe local reactions is more pronounced with 
the 3-injection regimen products. Only general ranges of adverse 
events can be obtained due to the variability of reporting 
